Research Article
Effectiveness of Early Favipiravir Therapy in Hospitalised COVID-19 Patients
Figure 4
Comparison between patients with comorbidities (n = 66) and without comorbidities (n = 37) in terms of the average length of stay in hospital (both groups were treated with favipiravir) ().